Stifel analysts updated their outlook on HubSpot Inc (NYSE: NYSE:HUBS), raising the stock's price target from the previous $880.00 to a new figure of $925.00. The firm continues to endorse the stock ...

Welcome to the Fortinet fourth quarter 2024 earnings announcement conference call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a ...

“We’re thinking in terms of 25% on Mexico and Canada because they’re allowing vast numbers of people ... from airbags and seat belts made by Autoliv to Michelin tires, are made in ...

10.22am: Investment trusts do deal with Saba Some more intrigue in the world of investment trusts this morning, where analysts at Stifel say ... in passenger numbers compared to a year ago and a fall ...

Stifel lowered the firm’s price target on Tesla (TSLA) to $474 from $492 and keeps a Buy rating on the shares. The firm cites the company’s “mixed” Q4 results, uncertainty caused by the ...

Good day and welcome to the Stifel Financial fourth quarter financial ... I would note that some of the numbers that we state throughout our presentation are presented on a non-GAAP basis and ...

Penn State revealed extensive details of the ongoing Beaver Stadium renovation project Thursday, including the temporary ...

At this time, I'd like to welcome everyone to the Q2 Holdings fourth quarter and full-year 2024 financial results conference call. (Operator Instructions) And with that, I would like to turn our call ...

Stifel noted that Reuters reported this morning ... NEC owns Netcracker, which is generally viewed as the number three player in the industry in terms of size, after Amdocs (DOX) and CSG, notes ...

Stifel has initiated coverage of Cytokinetics (NASDAQ:CYTK) with a buy rating, citing its drug aficamten. The bank noted the stock was "out of favor" in the wake of a "controversial" deal with ...

Stifel Financial (SF ... of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the ...

Blueprint Medicines Corporation ( NASDAQ: BPMC) Q4 2024 Earnings Conference Call February 13, 2025 8:00 AM ET ...